Line 13: | Line 13: | ||
background-size: cover; | background-size: cover; | ||
min-height: 100%; | min-height: 100%; | ||
− | + | ||
align-items: center; | align-items: center; | ||
justify-content: center; | justify-content: center; | ||
Line 23: | Line 23: | ||
} | } | ||
− | .insubiota-text { font: | + | .insubiota-text { font:72pt caviardreams, sans-serif; text-align: center; color:white } |
.insubiota-subtext { font:2em caviardreams, sans-serif; text-align: center; color:white } | .insubiota-subtext { font:2em caviardreams, sans-serif; text-align: center; color:white } |
Revision as of 13:41, 1 November 2017
iGEM AQA_Unesp
INSUBIOTA
treating diabetes with genetically engineered probiotic